11.21
0.88%
-0.10
시간 외 거래:
11.21
Pliant Therapeutics Inc 주식(PLRX)의 최신 뉴스
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Bakersfield Californian
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
11,678 Shares in Pliant Therapeutics, Inc. (NASDAQ:PLRX) Acquired by Deerfield Management Company L.P. Series C - Defense World
Pliant Therapeutics updates bylaws, aligns with Delaware law By Investing.com - Investing.com South Africa
Pliant Therapeutics updates bylaws, aligns with Delaware law By Investing.com - Investing.com UK
Investing in Pliant Therapeutics Inc (PLRX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Pliant Therapeutics Inc (PLRX) receives an Outperform rating from Leerink Partners - Knox Daily
Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains
5,372 Shares in Piper Sandler Companies (NYSE:PIPR) Purchased by Intech Investment Management LLC - MarketBeat
Berkley W R Corp Cuts Stock Position in Plum Acquisition Corp. I (NASDAQ:PLMI) - Defense World
Great Point Partners LLC Raises Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
Priority Technology (NASDAQ:PRTH) Reaches New 1-Year High After Analyst Upgrade - Defense World
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Sold by First Light Asset Management LLC - Defense World
First Light Asset Management LLC Sells 133,780 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat
Palfinger (OTCMKTS:PLFRY) Trading Down 2% - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - MarketBeat
Pulse Biosciences Inc [PLSE] Investment Appeal on the Rise - Knox Daily
Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Rhumbline Advisers Raises Stock Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat
Piper Sandler Companies (NYSE:PIPR) Shares Acquired by Commonwealth Equity Services LLC - Defense World
Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - Defense World
Pliant Therapeutics (NASDAQ:PLRX) Trading Down 2.7% - MarketBeat
Piper Sandler Companies (NYSE:PIPR) Rating Reiterated by JMP Securities - Defense World
JMP Securities Reaffirms “Market Perform” Rating for Piper Sandler Companies (NYSE:PIPR) - Defense World
Pliant Therapeutics (NASDAQ:PLRX) Stock Price Down 2.7% - Defense World
PLRX’s 52-Week Rollercoaster: From $10.29 to $19.62 – What’s Next for Investors? - The InvestChronicle
Piper Sandler maintains Overweight rating on Pliant Therapeutics shares By Investing.com - Investing.com Canada
Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - MarketBeat
What is the investor’s view on Pliant Therapeutics Inc (PLRX)? - US Post News
Statera Biopharma (NASDAQ:STAB) & Pliant Therapeutics (NASDAQ:PLRX) Financial Analysis - Defense World
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Purchased by Bank of New York Mellon Corp - Defense World
PLRX’s latest rating updates from top analysts. - Knox Daily
Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $12.00 - MarketBeat
Ratio Review: Analyzing Pliant Therapeutics Inc (PLRX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
This trade activity should not be overlooked: Pliant Therapeutics Inc (PLRX) - SETE News
HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX) - Defense World
Quest Partners LLC Has $346,000 Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
Analysts Set Pliant Therapeutics, Inc. (NASDAQ:PLRX) Target Price at $40.57 - MarketBeat
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX) - MarketBeat
Is Pliant Therapeutics (NASDAQ:PLRX) Using Too Much Debt? - Simply Wall St
Rice Hall James & Associates LLC Takes $1.37 Million Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat
Research Analysts Set Expectations for Pliant Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:PLRX) - Defense World
Brokers Set Expectations for Pliant Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:PLRX) - MarketBeat
Pliant Therapeutics: Good Data, But Will Need Watching (NASDAQ:PLRX) - Seeking Alpha
Pliant Therapeutics (NASDAQ:PLRX) Shares Down 4.2% - MarketBeat
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Forecasted to Post Q1 2025 Earnings of ($0.97) Per Share - Defense World
Pliant Therapeutics (NASDAQ:PLRX) Stock Rating Upgraded by Leerink Partnrs - Defense World
Trend Tracker for (PLRX) - Stock Traders Daily
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024 - Markets Insider
Leerink Partnrs Comments on Pliant Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:PLRX) - MarketBeat
Pliant Therapeutics (NASDAQ:PLRX) Lifted to "Strong-Buy" at Leerink Partnrs - MarketBeat
Pliant Therapeutics Presents Data from its Bexotegrast - GlobeNewswire
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory - The Bakersfield Californian
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024 - StockTitan
Pliant Therapeutics (NASDAQ:PLRX) Coverage Initiated by Analysts at Leerink Partners - Defense World
Candriam S.C.A. Has $8.96 Million Stock Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat
Leerink Partners sets Outperform rating on Pliant Therapeutics shares By Investing.com - Investing.com Canada
Pliant Therapeutics (NASDAQ:PLRX) Coverage Initiated at Leerink Partners - MarketBeat
Candriam S.C.A. Boosts Stock Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
Pliant Therapeutics to Participate in Upcoming Investor Events - GlobeNewswire
Pliant Therapeutics to Participate in Upcoming Investor Events - StockTitan
Pliant Therapeutics to Participate in Upcoming Investor Events - Yahoo Finance
Taking a Closer Look At Pliant Therapeutics Inc (PLRX) Following Its Recent Trade - Knox Daily
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - Markets Insider
There is no way Pliant Therapeutics Inc (PLRX) can keep these numbers up - SETE News
Investor’s Toolkit: Key Ratios for Assessing Pliant Therapeutics Inc (PLRX)’s Performance - The Dwinnex
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - ForexTV.com
Pliant Therapeutics Announces Four Upcoming Presentations - GlobeNewswire
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - StockTitan
자본화:
|
볼륨(24시간):